VITEK® SOLUTIONS – Innovating Microbiology
Innovating microbiology is at the heart of VITEK® SOLUTIONS. With our constant advances in workflow efficiency and integration, we provide fast and accurate ID & AST results to offer you critical insights for antimicrobial stewardship. . Efficient workflow equals efficient labs and time recaptured. VITEK® SOLUTIONS allows you to focus on challenging situations and value-added tasks. Designed by microbiologists for microbiologists, count on VITEK® SOLUTIONS to accompany all your ID & AST needs from routine to critical patient challenges.
Drive your Antimicrobial Stewardship (AMS) Programs with Diagnostics
VITEK® SOLUTIONS offers a fully integrated, automated ID & AST solution for faster and more reliable results. The regularly updated databases and panels keep pace with new emerging pathogens, clinically relevant species, and breakpoints to provide more informed decisions sooner to support AMS programs and improve patient care.
Make More Informed Therapy Decisions Sooner
Whether you are faced with routine testing, unusual or resistant organisms, or critical clinical situations, VITEK® SOLUTIONS enables you to confidently deliver results with excellent speed and accuracy. The combined solutions have been shown to get results to clinicians 14 to 20 hours earlier1,2,3, facilitating clinical decision-making for optimal treatment.4
VITEK® SOLUTIONS has constantly pushed back technology limits to improve patient care for over 30 years and will resolutely continue to do so.
VITEK® SOLUTIONS
The completeness of VITEK® SOLUTIONS provides multiple choices that can evolve over time to meet increasing productivity goals.
Disclaimer: Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.
Resources
VITEK® SOLUTIONS
Customer Testimonials
Testimonials
VITEK® 2 Testimonials
Testimonials
VITEK® 2 Testimonials
- Testimonial 1
- Testimonial 2
Contact Us
References
1. Kaleta and Wolk, Clin Lab News ; May 2012
2. Barenfanger et al. JCM 1999 37 (5) 1415
3. Galar et al. EJMID 2012 31 (9) 2445
4. Cavalieri SJ et al. Diagnostic Microbiology and Infectious Disease. 2019; Vol 92 (2):208-211. Effect of antimicrobial stewardship with rapid MALDI-TOF identification and VITEK® 2 antimicrobial susceptibility testing on hospitalization outcome: https://pubmed.ncbi.nlm.nih.gov/31279585/